Clinical Trial Update: The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Steovess/Binosto after stopping Denosumab to prevent a rebound increase in bone turnover in patients with erosive osteoarthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis

Drugs mentioned

• Steovess/Binosto

Snippet

Sponsor: University Hospital, Ghent | Conditions: Erosive Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-12-13